Laura Price

6.0k total citations
86 papers, 3.4k citations indexed

About

Laura Price is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Laura Price has authored 86 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 33 papers in Cardiology and Cardiovascular Medicine and 13 papers in Surgery. Recurrent topics in Laura Price's work include Pulmonary Hypertension Research and Treatments (62 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers) and Cardiovascular Issues in Pregnancy (10 papers). Laura Price is often cited by papers focused on Pulmonary Hypertension Research and Treatments (62 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers) and Cardiovascular Issues in Pregnancy (10 papers). Laura Price collaborates with scholars based in United Kingdom, France and United States. Laura Price's co-authors include Marc Humbert, Stephen J. Wort, David Montani, Peter Dorfmüller, Gérald Simonneau, Frédéric Perros, Olivier Sitbon, Xavier Jaïs, Sylvia Cohen‐Kaminsky and Barbara Girerd and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Laura Price

81 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Price United Kingdom	30	2.6k	1.2k	538	434	362	86	3.4k
James R. Klinger United States	36	3.6k 1.4×	2.3k 1.9×	648 1.2×	935 2.2×	567 1.6×	136	5.0k
Fumio Sakamaki Japan	29	3.0k 1.2×	1.9k 1.7×	466 0.9×	292 0.7×	436 1.2×	87	4.1k
Kelly Chin United States	30	4.0k 1.5×	2.8k 2.5×	517 1.0×	350 0.8×	343 0.9×	137	4.9k
Gábor Kovács Austria	39	3.4k 1.3×	2.4k 2.1×	421 0.8×	250 0.6×	172 0.5×	133	4.4k
Jacques Cerrina France	33	2.0k 0.8×	578 0.5×	1.1k 2.0×	399 0.9×	648 1.8×	84	3.4k
J. Simon R. Gibbs United Kingdom	36	4.6k 1.8×	3.4k 2.9×	652 1.2×	563 1.3×	303 0.8×	78	6.0k
P Duroux France	33	3.0k 1.2×	1.2k 1.0×	756 1.4×	459 1.1×	1.0k 2.8×	87	4.3k
Oliver Hartmann Germany	38	822 0.3×	1.3k 1.1×	451 0.8×	1.2k 2.7×	212 0.6×	142	4.9k
Cesar A. Keller United States	27	3.2k 1.2×	1.5k 1.3×	993 1.8×	153 0.4×	345 1.0×	79	3.8k
Birger Hesse Denmark	31	497 0.2×	1.5k 1.3×	892 1.7×	595 1.4×	468 1.3×	160	3.7k

Countries citing papers authored by Laura Price

Since Specialization

Citations

This map shows the geographic impact of Laura Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Price more than expected).

Fields of papers citing papers by Laura Price

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Price. The network helps show where Laura Price may publish in the future.

Co-authorship network of co-authors of Laura Price

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Price. A scholar is included among the top collaborators of Laura Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Price. Laura Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Price, Laura, Ifan Jenkin, Konstantinos Dimopoulos, et al.. (2025). Survival in Patients With Pulmonary Hypertension Associated With Fibrotic Interstitial Lung Disease is Independent of ILD Subtype: A London Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3281–A3281.

Sitbon, Olivier, Athénaïs Boucly, Jason Weatherald, et al.. (2025). Drugs targeting novel pathways in pulmonary arterial hypertension. European Respiratory Journal. 66(2). 2401830–2401830. 2 indexed citations

Alasmari, Ali, Laura Price, Colm McCabe, et al.. (2025). Dietary nitrate supplementation enhances exercise capacity in WHO Group 3 pulmonary hypertension: a double-blind, placebo-controlled, randomised crossover study (EDEN-OX2). Thorax. 80(5). 335–338.

Weatherald, Jason, Anna R. Hemnes, Bradley A. Maron, et al.. (2024). Phenotypes in pulmonary hypertension. European Respiratory Journal. 64(3). 2301633–2301633. 14 indexed citations

Arvanitaki, Alexandra, Gerhard‐Paul Diller, Michael Α. Gatzoulis, et al.. (2024). Noninvasive diagnostic modalities and prediction models for detecting pulmonary hypertension associated with interstitial lung disease: a narrative review. European Respiratory Review. 33(174). 240092–240092. 3 indexed citations

Huang, Tingting, et al.. (2024). A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia. PLoS ONE. 19(1). e0292375–e0292375. 1 indexed citations

Samaranayake, Chinthaka B., John W. Upham, Khoa D. Tran, et al.. (2023). Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study. BMJ Open Respiratory Research. 10(1). e001637–e001637. 4 indexed citations

Constantine, Andrew, Isma Rafiq, Ana Barradas‐Pires, et al.. (2023). Management of pulmonary arterial hypertension during pregnancy. Expert Review of Respiratory Medicine. 17(5). 413–423. 3 indexed citations

Samaranayake, Chinthaka B., Christopher Warren, Stephen J. Wort, et al.. (2023). Chaotic breathing in post-COVID-19 breathlessness: a key feature of dysfunctional breathing can be characterised objectively by approximate entropy. ERJ Open Research. 9(4). 117–2023. 8 indexed citations

10.

Groot, Rens de, Melissa Heightman, Toby Hillman, et al.. (2023). Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. Journal of Thrombosis and Haemostasis. 21(1). 94–100. 14 indexed citations

11.

Bianchi, Paolo, et al.. (2022). Percutaneous oxygenated right ventricular assist device for pulmonary embolism: A case series. Artificial Organs. 47(3). 595–603. 6 indexed citations

12.

Piccari, Lucilla, Stephen J. Wort, Federica Meloni, et al.. (2022). The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease. Respiration. 101(8). 717–727. 31 indexed citations

13.

Singh, Suveer, Simon Padley, Anand Devaraj, et al.. (2022). Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?. ERJ Open Research. 9(1). 389–2022. 3 indexed citations

14.

Price, Laura, Benjamin Garfield, Chloë I. Bloom, et al.. (2022). Persistent isolated impairment of gas transfer following COVID-19 pneumonitis relates to perfusion defects on dual-energy computed tomography. ERJ Open Research. 8(4). 224–2022. 7 indexed citations

15.

Samaranayake, Chinthaka B., Alex Pitcher, Thomas Semple, et al.. (2021). A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?. European Respiratory Journal. 57(6). 2004354–2004354. 8 indexed citations

16.

Keir, Gregory J., Stephen J. Wort, Maria Kokosi, et al.. (2018). Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization. Respirology. 23(7). 687–694. 45 indexed citations

17.

Blanche, C, Rafael Alonso-González, Aitor Uribarri, et al.. (2018). Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension. International Journal of Cardiology. 267. 79–83. 16 indexed citations

18.

Price, Laura, Stephen J. Wort, Simon J. Finney, Philip Marino, & Stephen J. Brett. (2010). Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Critical Care. 14(5). R169–R169. 219 indexed citations

19.

Price, Laura, David Montani, Colas Tchérakian, et al.. (2010). Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats. European Respiratory Journal. 37(4). 813–822. 76 indexed citations

20.

Montani, David, Xavier Jaïs, Laura Price, et al.. (2009). Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease. European Respiratory Journal. 34(6). 1348–1356. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact